RMD

Resmed Inc

229.94

Oct 30 • 3:59 PM ET -22.89 (-9.05%)

230.00

Aftermarket • 7:56 PM ET +0.06 (0.03%)

Healthcare Medical Instruments & Supplies USA Large NYSE

Oct 30, 8:32 PMUnchanged fiscal 2027 outlook and softer Q2 margin signals sink ResMed 9% after earnings

Peers: PHG INSP DXCM INGN AHCO MDT VMD LIVN ACH LLY

| Held by: VTI VOO VO IVV SPY RDVY XLV VUG VOT RSP

Scroll to Statements

Index	S&P 500
Market Cap	32.34B
Enterprise Value	31.92B
Income	1.59B
Sales	5.73B
Book/sh	42.29
Cash/sh	7.32
Dividend Est.	2.68 (1.16%)
Dividend TTM	2.46 (1.07%)
Dividend Ex-Date	Aug 20, 2026
Dividend Gr. 3/5Y	10.89% 9.00%
Payout	23.01%
Employees	11370
IPO	Jun 02, 1995

P/E	20.94
Forward P/E	17.33
PEG	1.89
P/S	5.64
P/B	5.44
P/C	31.42
P/FCF	20.10
EV/EBITDA	14.62
EV/Sales	5.57
Quick Ratio	1.88
Current Ratio	2.65
Debt/Eq	0.10
LT Debt/Eq	0.07
Option/Short	Yes / Yes

EPS (ttm)	10.98
EPS next Y	13.27
EPS next Q	3.00
EPS this Y	8.54%
EPS next Y	9.41%
EPS next 5Y	9.19%
EPS past 3/5Y	19.66% 26.34%
Sales past 3/5Y	10.21% 12.08%
EPS Y/Y TTM	12.22%
Sales Y/Y TTM	9.04%
EPS Q/Q	22.97%
Sales Q/Q	5.93%
Earnings	Oct 29 AMC
EPS/Sales Surpr.	8.33% 1.47%

Insider Own	0.94%
Insider Trans	-2.89%
Inst Own	75.10%
Inst Trans	0.63%
ROA	19.29%
ROE	26.40%
ROIC	25.02%
Gross Margin	60.49%
Oper. Margin	33.94%
Profit Margin	27.79%
SMA20	-3.93%
SMA50	-0.80%
SMA200	2.25%
Trades

Shs Outstand	140.64M
Shs Float	139.32M
Short Float	8.56%
Short Ratio	9.07
Short Interest	11.92M
52W High	277.67 -17.19%
52W Low	180.26 27.56%
Volatility	3.23% 2.55%
ATR (14)	6.90
RSI (14)	41.76
Beta	0.77
Rel Volume	2.64
Avg Volume	1.31M
Volume	3,470,546

Perf Week	-9.06%
Perf Month	3.97%
Perf Quarter	6.85%
Perf Half Y	12.15%
Perf YTD	-4.54%
Perf Year	-8.85%
Perf 3Y	67.29%
Perf 5Y	-12.54%
Perf 10Y	281.01%
Recom	2.07
Target Price	273.73
Prev Close	252.83
Price	229.94
Change %	-9.05%

Consensus

Buy

Avg. Price Target

$273.73

Implied Upside

+19.0%

Analysts13incl. previous ratings

Rating Distribution4 Buy · 8 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 15, 2026	Upgrade	RRBC Capital Mkts	Sector Perform → Outperform	$262	+13.9%
Aug 19, 2026	Initiated	RRothschild & Co Redburn	Neutral	$230	0.0%
Jul 16, 2026	Downgrade	RRBC Capital Mkts	Outperform → Sector Perform	$234	+1.8%
Jul 13, 2026	Downgrade	CCitigroup	Buy → Neutral	$235	+2.2%
Jun 17, 2026	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$230	0.0%
Apr 15, 2026	Initiated	JJP Morgan	Overweight
Dec 16, 2025	Downgrade	RRobert W. Baird	Outperform → Neutral	$275	+19.6%
Sep 18, 2025	Initiated	CCitigroup	Buy	$330	+43.5%
Sep 02, 2025	Upgrade	CCLSA	Hold → Outperform
Jul 15, 2025	Upgrade	RRBC Capital Mkts	Sector Perform → Outperform	$294	+27.9%
Mar 19, 2025	Initiated	MMorgan Stanley	Overweight	$280	+21.8%
Mar 19, 2025	Initiated	MMorgan Stanley	Overweight
Jan 16, 2025	Initiated	GGoldman	Buy
Jan 10, 2025	Initiated	PPiper Sandler	Neutral	$252	+9.6%
Dec 13, 2024	Initiated	SStifel	Hold	$250	+8.7%
Sep 24, 2024	Initiated	RRobert W. Baird	Outperform	$280	+21.8%
Sep 18, 2024	Downgrade	WWolfe Research	Peer Perform → Underperform	$180	-21.7%
Sep 04, 2024	Downgrade	NNeedham	Buy → Hold
Jun 25, 2024	Downgrade	OOppenheimer	Outperform → Perform
Jun 24, 2024	Downgrade	CCitigroup	Buy → Neutral

Oct-30-26 04:30PM	ResMed Inc. stock falls Friday, underperforms market (MarketWatch) -9.05%
07:36AM	ResMed Beats On Margin And Buybacks, But Unchanged Guidance Signals A Steady Rather Than Accelerating Year (Earnings Whispers)
Oct-29-26 04:16PM	ResMed: Fiscal Q1 Earnings Snapshot (Associated Press)
04:05PM	Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027 (GlobeNewswire)
Oct-22-26 06:48AM	ResMed's 18% Rally Meets A Thin Quarter As Astral And Margin Pressure Weigh (Earnings Whispers)
08:00AM	Loading…
Oct-19-26 08:00AM	Resmed Launches AirTouch F40 Full Face Fabric CPAP Mask in the U.S. (GlobeNewswire)
Oct-01-26 04:05PM	Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026 (GlobeNewswire)
Sep-28-26 04:25PM	Why DexCom Could Be the Big Winner Out of Oura's IPO (Barrons.com)
12:49PM	Is ResMed A Better Way Than Stryker To Own Medical Device Growth? (Trefis)
Sep-15-26 04:07PM	Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. (Barrons.com)
09:35AM	Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls (The Fly)
Aug-27-26 04:05PM	Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-25-26 09:00AM	23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs (GlobeNewswire)
Aug-19-26 09:38AM	Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls (The Fly)
Aug-17-26 04:10PM	Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor (GlobeNewswire)
07:08AM	Loading…
Aug-10-26 07:08AM	Resmeds stock falls by 7% on soft FY27 outlook (Medical Device Network)
Aug-07-26 08:41AM	ResMed Shares Fall After Revenue Miss and Conservative 2027 Outlook (InvestorsHub) -5.06%
01:12AM	ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Aug-06-26 04:35PM	ResMed: Fiscal Q4 Earnings Snapshot (Associated Press)
04:05PM	Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026 (GlobeNewswire)
Jul-21-26 04:40PM	BetterInvesting Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD) (PR Newswire)
Jul-16-26 09:33AM	SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls (The Fly)
Jul-08-26 04:30PM	ResMed Inc. stock falls Wednesday, underperforms market (MarketWatch) -6.33%
09:53AM	Resmed sharpens sleep care focus with $490m software business sale (Medical Device Network)
08:12AM	Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over' (Proactive)
07:28AM	Resmed to sell MatrixCare for $490M to private equity firm (MedTech Dive)
Jul-07-26 06:07PM	ResMed to sell software business MatrixCare for $490 million (Reuters)
05:06PM	Frazier Healthcare Partners Announces Definitive Agreement to Acquire MatrixCare (Business Wire)
04:30PM	Resmed Announces Agreement to Sell MatrixCare Business (GlobeNewswire)
Jun-30-26 04:30PM	Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026 (GlobeNewswire)
09:47AM	Loading…
Jun-17-26 09:47AM	Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls (The Fly)
Jun-04-26 07:17AM	ResMed completes $340m Noctrix Health acquisition (Medical Device Network)
Jun-02-26 02:30AM	Resmed completes $340M Noctrix takeover (MedTech Dive)
Jun-01-26 04:05PM	Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio (GlobeNewswire)
May-29-26 04:30PM	ResMed Inc. stock falls Friday, underperforms market (MarketWatch) -6.32%
May-19-26 04:05PM	Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference (GlobeNewswire)
09:00AM	Resmed and OURA Partner to Expand Access to Sleep Health Education and Care (GlobeNewswire)
May-01-26 03:18AM	ResMed Inc (RMD) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions (GuruFocus.com)
Apr-30-26 04:13PM	ResMed: Fiscal Q3 Earnings Snapshot (Associated Press)
04:10PM	Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor (GlobeNewswire)
04:05PM	Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026 (GlobeNewswire)
Apr-01-26 04:05PM	Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 (GlobeNewswire)
Mar-12-26 06:48AM	Is ResMed Stock Underperforming the Nasdaq? (Barchart)
Mar-03-26 03:00AM	Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach (GlobeNewswire)
Feb-25-26 08:43AM	4 GARP Stocks That Investors Can Scoop Up for Maximum Returns (Zacks)
Feb-24-26 09:00AM	Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana (GlobeNewswire)
Feb-18-26 11:10AM	ResMed Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Feb-15-26 11:03PM	ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
06:53AM	ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings (Insider Monkey)
Feb-13-26 09:29PM	Analyst Report: ResMed Inc. (Morningstar Research)
Feb-10-26 04:14PM	Top Stock Reports for NVIDIA, Amazon & Regeneron (Zacks)
11:43AM	CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market (Zacks)
11:11AM	ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market (Zacks)
04:03AM	Zacks.com featured highlights include Amphenol, GE Aerospace, ResMed and Ameriprise Financial (Zacks)
Feb-09-26 11:31AM	Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns (Zacks)
Feb-06-26 08:22PM	Analyst Report: ResMed Inc. (Morningstar Research)
08:03AM	RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
Feb-05-26 08:09AM	ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down (Zacks)
12:44AM	The Top 5 Analyst Questions From ResMed's Q4 Earnings Call (StockStory)
Feb-03-26 12:02PM	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
11:18AM	Silver Economy Boom: Investing in Healthcare's Aging Tailwinds (Zacks)
05:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Revised) (Zacks)
Feb-02-26 08:53PM	ResMed Inc. (RMD): A Bull Case Theory (Insider Monkey)
09:42AM	IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
09:08AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
Jan-30-26 01:08PM	Analysts Maintain Bull Case On ResMed Despite Competition Concerns (Benzinga)
11:45AM	Analyst Report: ResMed Inc. (Morningstar Research)
01:36AM	ResMed Q2 Earnings Call Highlights (MarketBeat)
12:33AM	RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth (StockStory)
12:04AM	ResMed Inc (RMD) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations (GuruFocus.com)
Jan-29-26 05:30PM	ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	ResMed (RMD) Q2 Earnings and Revenues Beat Estimates (Zacks)
05:07PM	ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations (StockStory)
04:15PM	ResMed: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 (GlobeNewswire)
09:50AM	Here's Why ResMed (RMD) is a Strong Momentum Stock (Zacks)
09:40AM	Are Medical Stocks Lagging ResMed (RMD) This Year? (Zacks)
08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Jan-28-26 12:10PM	Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:24AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
Jan-27-26 10:08PM	ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
11:52AM	UnitedHealth Q4 Earnings Beat on Strong Optum Rx, Offers 2026 Outlook (Zacks)
09:15AM	Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:54AM	Resmed's Q2 Earnings on Deck: What's in Store for the Stock? (Zacks)
Jan-26-26 09:45AM	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
Jan-22-26 10:00AM	ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
06:13AM	AdvaMed leaders on tariffs, MDUFA and wearables (MedTech Dive)
Jan-15-26 09:22AM	Bet on These 5 Low-Leverage Stocks to Avoid Industrial Volatilities (Zacks)
08:30AM	Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today (Zacks)
Jan-14-26 10:37PM	Reflecting On Patient Monitoring Stocks' Q3 Earnings: ResMed (NYSE:RMD) (StockStory)
Jan-13-26 11:04PM	ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
09:50AM	Why ResMed (RMD) is a Top Momentum Stock for the Long-Term (Zacks)
Jan-08-26 04:05PM	Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 (GlobeNewswire)
09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-05-26 03:57AM	What You Need to Know Ahead of ResMed's Earnings Release (Barchart)
Dec-30-25 12:45PM	Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
08:20AM	Buy These 5 Low-Leverage Stocks Amid a Reversal of Santa Claus Rally (Zacks)
08:20AM	BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? (Zacks)
07:33AM	3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rider Michael J	Global General Counsel	Oct 23 '26	Sale	255.00	400	102,000	12,318	Oct 26 03:39 PM
Rider Michael J	Officer	Oct 23 '26	Proposed Sale	255.00	400	102,000		Oct 23 12:28 PM
Farrell Michael J.	Chairman and CEO	Oct 07 '26	Option Exercise	146.34	4,991	730,383	484,794	Oct 08 05:31 PM
Farrell Michael J.	Chairman and CEO	Oct 07 '26	Sale	226.33	4,991	1,129,637	479,803	Oct 08 05:31 PM
Farrell Michael J.	Officer	Oct 07 '26	Proposed Sale	226.33	4,991	1,129,638		Oct 07 04:22 PM
Farrell Michael J.	Chairman and CEO	Sep 08 '26	Option Exercise	146.34	4,991	730,383	471,247	Sep 10 06:40 AM
Farrell Michael J.	Chairman and CEO	Sep 08 '26	Sale	222.44	4,991	1,110,191	466,256	Sep 10 06:40 AM
Farrell Michael J.	Officer	Sep 08 '26	Proposed Sale	226.22	4,991	1,129,064		Sep 08 01:21 PM
FARRELL PETER C	Director	Sep 02 '26	Sale	234.73	970	227,688	51,803	Sep 04 06:30 AM
Peter C Farrell	Director	Sep 02 '26	Proposed Sale	234.65	970	227,608		Sep 02 07:16 PM
Farrell Michael J.	Chairman and CEO	Aug 07 '26	Option Exercise	146.34	4,991	730,383	471,247	Aug 11 06:30 AM
Farrell Michael J.	Chairman and CEO	Aug 07 '26	Sale	205.69	4,991	1,026,596	466,256	Aug 11 06:30 AM
Farrell Michael J.	Officer	Aug 07 '26	Proposed Sale	205.69	4,991	1,026,596		Aug 07 10:58 AM
FARRELL PETER C	Director	Aug 05 '26	Sale	225.00	8,000	1,800,000	52,773	Aug 06 02:29 PM
Peter C Farrell	Director	Aug 05 '26	Proposed Sale	224.96	8,000	1,799,643		Aug 05 08:37 PM
Farrell Michael J.	Chairman and CEO	Jul 07 '26	Option Exercise	146.34	4,991	730,383	471,214	Jul 09 07:40 AM
Farrell Michael J.	Chairman and CEO	Jul 07 '26	Sale	218.55	4,991	1,090,771	466,223	Jul 09 07:40 AM
Farrell Michael J.	Officer	Jul 07 '26	Proposed Sale	219.34	4,991	1,094,726		Jul 07 10:07 AM
Farrell Michael J.	Chairman and CEO	Jun 08 '26	Option Exercise	146.34	4,991	730,383	471,214	Jun 09 02:26 PM
Farrell Michael J.	Chairman and CEO	Jun 08 '26	Sale	193.96	4,991	968,064	466,256	Jun 09 02:26 PM
Farrell Michael J.	Officer	Jun 08 '26	Proposed Sale	194.00	4,991	968,254		Jun 08 10:21 AM
Sandercock Brett	Former Officer	May 27 '26	Proposed Sale	209.07	8,000	1,672,560		May 27 11:23 AM
Farrell Michael J.	Chairman and CEO	May 07 '26	Option Exercise	146.34	4,991	730,383	471,214	May 11 07:33 AM
Farrell Michael J.	Chairman and CEO	May 07 '26	Sale	207.82	4,991	1,037,233	466,223	May 11 07:33 AM
Farrell Michael J.	Officer	May 07 '26	Proposed Sale	207.82	4,991	1,037,233		May 07 04:28 PM
Farrell Michael J.	Chairman and CEO	Apr 07 '26	Option Exercise	146.34	4,991	730,383	471,214	Apr 09 11:44 AM
Farrell Michael J.	Chairman and CEO	Apr 07 '26	Sale	225.50	4,991	1,125,486	466,223	Apr 09 11:44 AM
Farrell Michael J.	Officer	Apr 07 '26	Proposed Sale	225.50	4,991	1,125,486		Apr 07 04:13 PM
Sandercock Brett	Chief Financial Officer	Apr 01 '26	Sale	224.31	1,000	224,310	83,495	Apr 03 07:29 AM
FARRELL PETER C	Director	Apr 01 '26	Sale	225.00	2,000	450,000	60,773	Apr 02 01:52 PM
Peter C Farrell	Director	Apr 01 '26	Proposed Sale	224.96	2,000	449,920		Apr 01 05:30 PM
Sandercock Brett	Officer	Apr 01 '26	Proposed Sale	224.31	1,000	224,310		Apr 01 10:11 AM
Farrell Michael J.	Chairman and CEO	Mar 09 '26	Option Exercise	146.34	4,991	730,383	471,214	Mar 11 08:29 AM
Farrell Michael J.	Chairman and CEO	Mar 09 '26	Sale	251.03	4,991	1,252,902	466,223	Mar 11 08:29 AM
Farrell Michael J.	Officer	Mar 09 '26	Proposed Sale	250.08	4,991	1,248,149		Mar 09 11:24 AM
FARRELL PETER C	Director	Mar 04 '26	Sale	260.22	2,000	520,440	62,773	Mar 05 02:51 PM
Peter C Farrell	Director	Mar 04 '26	Proposed Sale	260.18	2,000	520,360		Mar 04 06:23 PM
Sandercock Brett	Chief Financial Officer	Mar 02 '26	Sale	254.30	1,000	254,300	84,495	Mar 03 04:29 PM
Sandercock Brett	Officer	Mar 02 '26	Proposed Sale	254.30	1,000	254,300		Mar 02 11:41 AM
Farrell Michael J.	Chairman and CEO	Feb 09 '26	Option Exercise	146.34	4,991	730,383	471,214	Feb 10 01:33 PM
Farrell Michael J.	Chairman and CEO	Feb 09 '26	Sale	273.78	4,991	1,366,436	466,223	Feb 10 01:33 PM
Farrell Michael J.	Officer	Feb 09 '26	Proposed Sale	273.78	4,991	1,366,436		Feb 09 04:17 PM
FARRELL PETER C	Director	Feb 04 '26	Sale	251.31	2,000	502,620	64,773	Feb 06 11:07 AM
Rider Michael J	Global General Counsel	Feb 04 '26	Sale	260.00	50	13,000	9,691	Feb 06 11:05 AM
Peter C Farrell	Director	Feb 04 '26	Proposed Sale	251.27	2,000	502,540		Feb 04 06:53 PM
Rider Michael J	Officer	Feb 04 '26	Proposed Sale	260.00	50	13,000		Feb 04 10:59 AM
Sandercock Brett	Chief Financial Officer	Feb 02 '26	Sale	257.03	1,000	257,030	85,495	Feb 03 03:06 PM
Sandercock Brett	Officer	Feb 02 '26	Proposed Sale	257.03	1,000	257,030		Feb 02 03:15 PM
FARRELL PETER C	Director	Jan 07 '26	Sale	248.83	2,000	497,660	66,773	Jan 09 07:33 AM
Farrell Michael J.	Chairman and CEO	Jan 07 '26	Option Exercise	146.34	4,991	730,383	471,214	Jan 08 03:23 PM
Farrell Michael J.	Chairman and CEO	Jan 07 '26	Sale	248.46	4,991	1,240,065	466,223	Jan 08 03:23 PM
Peter C Farrell	Director	Jan 07 '26	Proposed Sale	248.79	2,000	497,580		Jan 07 05:03 PM
Farrell Michael J.	Officer	Jan 07 '26	Proposed Sale	248.46	4,991	1,240,065		Jan 07 04:17 PM
Sandercock Brett	Chief Financial Officer	Jan 02 '26	Sale	241.75	1,000	241,750	86,495	Jan 05 05:27 PM
Rider Michael J	Global General Counsel	Jan 02 '26	Sale	241.75	50	12,088	9,741	Jan 05 01:18 PM
Sandercock Brett	Officer	Jan 02 '26	Proposed Sale	241.75	1,000	241,750		Jan 02 12:45 PM
Rider Michael J	Officer	Jan 02 '26	Proposed Sale	241.75	50	12,088		Jan 02 10:56 AM
Farrell Michael J.	Chairman and CEO	Dec 08 '25	Option Exercise	146.34	4,991	730,383	471,214	Dec 09 03:17 PM
Farrell Michael J.	Chairman and CEO	Dec 08 '25	Sale	251.41	4,991	1,254,796	466,223	Dec 09 03:17 PM
Farrell Michael J.	Officer	Dec 08 '25	Proposed Sale	251.41	4,991	1,254,796		Dec 08 04:13 PM
FARRELL PETER C	Director	Dec 03 '25	Sale	251.47	2,000	502,940	68,773	Dec 04 01:46 PM
Peter C Farrell	Director	Dec 03 '25	Proposed Sale	251.43	2,000	502,860		Dec 03 04:20 PM
Rider Michael J	Global General Counsel	Dec 01 '25	Sale	244.16	50	12,208	9,791	Dec 02 04:27 PM
Sandercock Brett	Chief Financial Officer	Dec 01 '25	Sale	244.16	1,000	244,160	87,495	Dec 02 04:23 PM
Sandercock Brett	Officer	Dec 01 '25	Proposed Sale	244.16	1,000	244,160		Dec 01 12:11 PM
Rider Michael J	Officer	Dec 01 '25	Proposed Sale	244.16	50	12,208		Dec 01 12:08 PM
De Witte Jan	Director	Nov 25 '25	Sale	255.00	2,055	524,025	4,261	Nov 26 02:40 PM
De Witte Jan	Director	Nov 25 '25	Proposed Sale	255.00	2,055	524,025		Nov 25 03:22 PM
FARRELL PETER C	Director	Nov 14 '25	Option Exercise	101.64	11,442	1,162,965	77,552	Nov 18 04:59 PM
FARRELL PETER C	Director	Nov 12 '25	Sale	252.05	2,000	504,100	66,110	Nov 13 05:39 PM
De Witte Jan	Director	Nov 11 '25	Sale	250.25	487	121,872	5,319	Nov 13 05:24 PM
Peter C Farrell	Director	Nov 12 '25	Proposed Sale	252.05	2,000	504,100		Nov 12 05:21 PM
De Witte Jan	Director	Nov 11 '25	Proposed Sale	250.25	487	121,872		Nov 12 06:44 AM
Farrell Michael J.	Chairman and CEO	Nov 07 '25	Option Exercise	101.64	8,011	814,238	475,877	Nov 10 07:07 PM
Farrell Michael J.	Chairman and CEO	Nov 07 '25	Sale	249.75	8,011	2,000,773	467,866	Nov 10 07:07 PM
Farrell Michael J.	Officer	Nov 07 '25	Proposed Sale	249.75	8,011	2,000,773		Nov 07 04:12 PM
Sandercock Brett	Chief Financial Officer	Nov 03 '25	Option Exercise	101.64	2,000	203,280	88,745	Nov 04 04:02 PM
Sandercock Brett	Chief Financial Officer	Nov 03 '25	Sale	247.54	3,000	742,620	85,745	Nov 04 04:02 PM
Sandercock Brett	Officer	Nov 03 '25	Proposed Sale	247.54	3,000	742,620		Nov 03 10:25 AM

ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. The Sleep and Breathing Health segment relates primarily to the sale of therapy-based equipment. The Residential Care Software segment provides software access with ongoing support and maintenance services as well as professional services such as training and consulting. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

MBAMr. Michael J. Farrell BE

B.E.Dr. Peter C. Farrell A.M.

Chief Financial OfficerMr. Aaron Bloomer

Chief Legal Officer & SecretaryMr. Michael J. Rider

AdvisorMr. Brett A. Sandercock

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RMD

Resmed Inc

Upgrade your Finviz experience